Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities
Net income	$ 45,824,328	$ 10,019,797
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	19,075,353	18,114,440
Impairment of goodwill and intangibles	2,431,791	324,306
Share-based compensation	2,743,116	1,954,238
Unrealized gain from investment in equity securities	(86,005)	0
Gain on settlement of preexisting note receivable from ApolloMed	(921,938)	0
Gain from investments - fair value adjustments	(13,697,018)	0
Change in fair value of derivative instrument	44,886	(1,722,221)
Loss (income) from equity method investments	1,112,541	(4,748,542)
Deferred tax	(20,675,807)	(3,009,779)
Changes in operating assets and liabilities, net of acquisition amounts:
Change in restricted cash	95,456	(756)
Receivable, net	10,702,753	8,703,162
Prepaid expenses and other current assets	1,260,064	(172,311)
Other assets	(220,925)	(63,353)
Accounts payable and accrued expenses	(3,687,022)	1,927,121
Capitation incentives payable	1,878,355	5,182,665
Medical liabilities	5,661,313	2,945,946
Income taxes payable	388,138	(17,540,939)
Net cash provided by operating activities	51,929,379	21,913,774
Cash flows from investing activities
Cash acquired in the Merger	36,367,555	0
Cash received from consolidation of VIE	228,287	0
Purchases of marketable securities	(5,283)	(10,447)
Restricted cash	(18,000,000)	0
Proceeds from loans receivable	200,000	0
Advances on loans receivable	(10,000,000)	0
Advances to related parties - loans receivable	0	(200,000)
Dividends received from equity method investments	1,240,000	2,000,000
Proceeds on sale of investments - cost method	25,000	0
Purchases of investments - cost method	0	(5,000,000)
Purchases of investments - equity method	0	(2,440,000)
Purchases of property and equipment	(2,084,770)	(3,306,294)
Net cash provided by (used in) investing activities	7,970,789	(8,956,741)
Cash flows from financing activities
Repayment of loan payable - related party	0	(600,000)
Dividends paid	(10,447,923)	(26,659,119)
Change in noncontrolling interest capital	0	1,124,320
Borrowings on line of credit	5,000,000	0
Advances by NMM to ApolloMed prior to the Merger	(9,000,000)	0
Principal payments on bank loan	0	(1,477,561)
Payment of capital lease obligations	(102,348)	(181,008)
Proceeds from exercise of stock options included in liabilities	425,025	0
Proceeds from exercise of stock options	164,797	260,000
Proceeds from common stock offering	2,160,736	10,903,700
Repurchase of common shares	(3,175,836)	(517,500)
Net cash used in financing activities	(14,975,549)	(17,147,168)
Net increase (decrease) in cash and cash equivalents	44,924,619	(4,190,135)
Cash and cash equivalents, beginning of year	54,824,580	59,014,715
Cash and cash equivalents, end of year	99,749,199	54,824,580
Supplemental disclosures of cash flow information
Cash paid for income taxes	24,362,223	29,366,184
Cash paid for interest	51,043	61,589
Supplemental disclosures of non-cash investing and financing activities
Stock issued in connection with acquisitions	0	5,155,000
Deferred tax liability adjusted to goodwill	0	977,817
Equipment purchased with capital lease	0	186,092
Dividends declared included in dividends payable and restricted cash	18,000,000	0
Distribution of warrants to former NMM shareholders	5,294,000	0
Issuance of common stock upon conversion of debt and accrued interest	5,376,215	0
Reclassification of liability for unissued common shares payable to equity	1,237,650	0
Reclassification of fiduciary cash to payable	966,698	1,313,395
Unvested Stock Compensation [Member]
Supplemental disclosures of non-cash investing and financing activities
Non-cash purchase consideration for acquisition	187,333	0
Preferred Stock [Member]
Supplemental disclosures of non-cash investing and financing activities
Non-cash purchase consideration for acquisition	19,118,000	0
Equity [Member]
Supplemental disclosures of non-cash investing and financing activities
Non-cash purchase consideration for acquisition	61,092,050	0
Network Medical Management, Inc. [Member]
Supplemental disclosures of non-cash investing and financing activities
Non-cash purchase consideration for acquisition	$ 5,129,000	$ 0